Evaluation of ICP-B794 in Patients With Advanced Solid Tumors

NCT07136558 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ICP-B794

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.